0R15 8106.3789 -2.591% 0R1E 7522.4966 -1.8975% 0M69 17684.8301 40.4673% 0R2V 173.13 -1.4908% 0QYR 1393.2542 -0.4463% 0QYP 414.6301 -1.8627% 0LCV 143.625 0.3669% 0RUK 3040.8877 4.0687% 0RYA 1710.0 -1.9495% 0RIH 158.6 0.1263% 0RIH 154.23 -2.6326% 0R1O 183.63 9719.7861% 0R1O None None% 0QFP 9391.9473 86.3482% 0M2Z 304.7872 0.004% 0VSO 24.79 -30.3749% 0R1I None None% 0QZI 510.0 -1.1628% 0QZ0 220.0 0.0% 0NZF 880.3253 76.6303%

Healthcare Report

Plant Health Care PLC

Jun 30, 2022

PHC:LSE
Investment Type
Small-Cap
Risk Level
Action
Rec. Price ()

Section1: Company Overview and Fundamental Insights

1.1 Company Overview:

Plant Health Care PLC is an FTSE AIM All-Share index listed leading provider of proprietary biological products to global agricultural markets. The Company offer products to enhance the health, vigour, and yield of major field crops such as corn, soybeans, cotton, and rice.

1.2 The Key Positives, Negatives, Investment Highlights and Risks

1.3 Top 10 Shareholders:

The top 10 shareholders collectively form ~66.99% of the total shareholdings. Ospraie Ag Science LLC holds the maximum number of shares with ~17.88% shareholding, followed by Griffiths (Richard Ian) with ~13.95%, as depicted in the chart below: 

1.4 Key Metrics:

The Company’s current ratio has increased to 4.73x in FY21 and gross profit grew at a CAGR of ~5.15% between FY16 and FY21.

Section 2:  Business Updates and Financial Highlights

2.1 Recent Developments

2.2 FY21 Financial Highlights (for the year ended 31 December 2021, as of 12 May 2022)


Section 3:  Key Risks and Outlook

Section 4: Stock Recommendation Summary

4.1 Price Performance and Technical Summary:

4.2 Fundamental Valuation

Valuation Methodology: EV/Sales Approach (FY22E) (Illustrative)

Please note markets are trading in a highly volatile zone currently due to certain macro-economic and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: The reference data in this report has been partly sourced from REFINITIV.

Note 2: Investment decisions should be made depending on the investors’ appetite for upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the Valuation has been achieved and is subject to the factors discussed above.

Note 3: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 4:  Kalkine reports are prepared based on the stock prices captured either from the London Stock Exchange (LSE) and or REFINITIV. Typically, both sources (LSE and or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and uptrend may take a pause due to profit booking or selling interest.

Stop-loss: In general, it is a level to protect further losses in case of any unfavourable movement in the stock prices.


Disclaimer

References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.

This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Kalkine Media Limited, an affiliate of Kalkine Limited, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions